• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters Chloropropanol esters

Recent Advances in the Study of rac 1-Heptandecanoyl-3-chloropropanediol (CAS: 87505-04-2)

In recent years, the compound rac 1-Heptandecanoyl-3-chloropropanediol (CAS: 87505-04-2) has garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has been the subject of numerous studies aimed at exploring its potential applications in drug development, chemical synthesis, and biological activity modulation. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its synthesis, properties, and potential therapeutic uses.

Recent studies have focused on the synthesis and optimization of rac 1-Heptandecanoyl-3-chloropropanediol, with particular emphasis on improving yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel enzymatic approach to synthesizing this compound, which demonstrated higher efficiency and reduced environmental impact compared to traditional chemical methods. The study also explored the stereochemical implications of the racemic mixture, providing insights into its biological activity and potential for chiral resolution.

The biological activity of rac 1-Heptandecanoyl-3-chloropropanediol has been another area of intense investigation. Preliminary in vitro studies have shown that this compound exhibits moderate inhibitory effects on certain cancer cell lines, particularly those associated with breast and prostate cancers. Researchers hypothesize that the chloropropanediol moiety may play a critical role in its mechanism of action, possibly through interaction with cellular signaling pathways. Further in vivo studies are currently underway to validate these findings and assess the compound's pharmacokinetic properties.

In addition to its potential therapeutic applications, rac 1-Heptandecanoyl-3-chloropropanediol has also been studied for its utility in chemical biology. A recent study published in Chemical Communications demonstrated its use as a versatile building block for the synthesis of more complex molecules, including lipid analogs and prodrugs. The compound's ability to undergo selective acylation and chlorination reactions makes it a valuable tool for synthetic chemists working in drug discovery and development.

Despite these promising findings, challenges remain in the development and application of rac 1-Heptandecanoyl-3-chloropropanediol. Issues such as stability, solubility, and potential toxicity need to be addressed before it can be considered for clinical use. Ongoing research is focused on optimizing the compound's physicochemical properties and exploring its interactions with biological targets at the molecular level. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate progress in this area.

In conclusion, rac 1-Heptandecanoyl-3-chloropropanediol (CAS: 87505-04-2) represents a promising candidate for further investigation in the fields of drug development and chemical biology. The latest research highlights its potential as a therapeutic agent and a versatile synthetic intermediate, while also underscoring the need for additional studies to overcome existing limitations. As the scientific community continues to explore the full scope of its applications, this compound is likely to play an increasingly important role in advancing our understanding of chemical-biological interactions and the development of novel pharmaceuticals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)